Home Sleep Screening Devices Market Size is expected to record a commendable CAGR from 2022 to 2028. This rise is attributed to the growing demand for home sleep test devices that provide the advantage of enabling testing with less instrumentation and in the patient’s home. Furthermore, HSTs are less expensive and are available on an extensive scale as compared to in-facility PSGs. Therefore, the increasing adoption of these tests for the diagnosis of OSA is slated to push industry expansion through the coming years.
On the basis of product, the wearables segment is anticipated to register substantial growth by 2028 owing to an increase in the development of new products by prominent industry players. For instance, in November 2021, UK-based medical device firm, Acurable’s AcuPebble SA100 secured the FDA 510(k) clearance as a Class II medical device in the U.S. The solution is a small wearable that enables remote, automated home testing for the detection of OSA (obstructive sleep apnea) in adults.
Based on application, the sleep apnea segment accounted for a considerable share in the home sleep screening devices market through 2028. This growth is credited to an increase in the deployment of simplified home sleep apnea testing services for the diagnosis of the disorder. The tests usually measure a patient’s breathing patterns, airflow, blood oxygen level, and heart rate. In cases where the results are abnormal, healthcare professionals can prescribe a therapy without further testing.
Citing the regional landscape, North America home sleep screening devices market is estimated to record lucrative expansion during the forecast period. This upsurge is due to a rise in discussions conducted by various organizations. For instance, one of the ‘Talking Sleep’ sessions, conducted by the American Academy of Sleep Medicine, discussed the relationship between cardiovascular disease and OSA and the highlighted the need for collaborating with the cardiology sector for improving the diagnosis and treatment of OSA.
Key participants in the home sleep screening devices market comprise NovaSom, Koninklijke Philips, Itamar Medical (ZOLL Medical), VirtuOx, Cleveland Medical Devices, ResMed, ApneaMed, Garmin, SleepWorks, Dream Sleep, and others. These companies are focused on the adoption of strategic initiatives such as mergers, acquisitions, partnerships, product developments, and collaborations for the consolidation of their position in the home sleep screening devices market.
Some of the instances have been mentioned below:
The COVID-19 pandemic has created the challenge for the restart of sleep screening services in a manner that is reassuring and safe to patients. Numerous service providers are, therefore, focused on the screening of sleep referrals for SARS-CoV-2 symptoms and signs, the distribution of home sleep testing devices, and the return of these devices with disinfection for reuse. The issuance of guidelines by several regulatory bodies in this regard is predictedto drive the home sleep screening devices market expansion through the pandemic period.
Market, by Product Type
Market, by Application
Market, by Distribution Channel
The above information is provided for the following regions and countries: